These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2701315)

  • 1. Comparison of the behavioral effects and abuse liability of ethanol and pentobarbital in recreational sedative abusers.
    Guarino JJ; Roache JD; Kirk WT; Griffiths RR
    NIDA Res Monogr; 1989; 95():453-4. PubMed ID: 2701315
    [No Abstract]   [Full Text] [Related]  

  • 2. Zolpidem and triazolam in humans: behavioral effects and abuse liability.
    Evans SM; Griffiths RR
    NIDA Res Monogr; 1989; 95():431-2. PubMed ID: 2701312
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of fluvoxamine, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers.
    Linnoila M; Stapleton JM; George DT; Lane E; Eckardt MJ
    J Clin Psychopharmacol; 1993 Jun; 13(3):175-80. PubMed ID: 8354733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethanol and pentobarbital: comparison of behavioral and subjective effects in sedative drug abusers.
    Mintzer MZ; Guarino J; Kirk T; Roache JD; Griffiths RR
    Exp Clin Psychopharmacol; 1997 Aug; 5(3):203-15. PubMed ID: 9260068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subjective effects of methaqualone.
    Ionescu-Pioggia M; Bird M; Cole JO
    NIDA Res Monogr; 1989; 95():455. PubMed ID: 2701316
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental assessment of the relative abuse liability of triazolam and pentobarbital.
    Roache JD; Griffiths RR
    NIDA Res Monogr; 1984; 55():106-10. PubMed ID: 6443368
    [No Abstract]   [Full Text] [Related]  

  • 8. Human psychopharmacology of intranasal cocaine.
    Higgins ST; Hughes JR; Bickel WK
    NIDA Res Monogr; 1989; 95():357-8. PubMed ID: 2701303
    [No Abstract]   [Full Text] [Related]  

  • 9. [Considering the psychotropic effect of alcohol].
    von Wartburg JP
    Ther Umsch; 1990 May; 47(5):399-404. PubMed ID: 2195700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of triazolam and ethanol on awareness, memory, and psychomotor performance.
    Roache JD; Cherek DR; Bennett RH; Schenkler JC; Cowan KA
    J Clin Psychopharmacol; 1993 Feb; 13(1):3-15. PubMed ID: 8486815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans.
    Evans SM; Troisi JR; Griffiths RR
    J Pharmacol Exp Ther; 1994 Nov; 271(2):683-94. PubMed ID: 7965783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential response to alcohol in light and moderate female social drinkers.
    Evans SM; Levin FR
    Behav Pharmacol; 2004 May; 15(3):167-81. PubMed ID: 15187575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of triazolam and pentobarbital: performance impairment, subjective effects and abuse liability.
    Roache JD; Griffiths RR
    J Pharmacol Exp Ther; 1985 Jul; 234(1):120-33. PubMed ID: 2861282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preference for ethanol in males with or without an alcoholic first degree relative.
    de Wit H; McCracken SG
    NIDA Res Monogr; 1989; 95():374-5. PubMed ID: 2701305
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the abuse potential of the novel analgesic flupirtine maleate.
    Preston KL; Funderburk FR; Liebson IA; Bigelow GE
    Drug Alcohol Depend; 1991 Mar; 27(2):101-13. PubMed ID: 2055157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital.
    Zawertailo LA; Busto UE; Kaplan HL; Greenblatt DJ; Sellers EM
    J Clin Psychopharmacol; 2003 Jun; 23(3):269-80. PubMed ID: 12826989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of alprazolam in chronic therapeutic users.
    Lucki I; Kerr LA; Fridman RB; Schweizer E; Rickels K
    NIDA Res Monogr; 1989; 95():464. PubMed ID: 2701317
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of prostaglandin synthesis and effects of ethanol and pentobarbital in humans.
    Pickworth WB; Fant RV; Henningfield JE
    J Pharmacol Exp Ther; 1997 Oct; 283(1):274-80. PubMed ID: 9336333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alprazolam absorption kinetics affects abuse liability.
    Mumford GK; Evans SM; Fleishaker JC; Griffiths RR
    Clin Pharmacol Ther; 1995 Mar; 57(3):356-65. PubMed ID: 7697954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.